Abstract
Caroline Hofmans, Paolo Vercellini, Edgardo Somigliana, Michael D. Mueller, Dan C. Martin, Annemiek Nap, Andrea Romano, Fernando Reis, Michel Canis
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Diagnosis of endometriosis
10.1055/s-2008-1068752 · 1997
Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women
10.1093/humrep/deg136 · 2003
Diagnostic delay in women with pain and endometriosis
10.1034/j.1600-0412.2003.00168.x · 2003
An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis
10.1002/ijgo.12521 · 2018
Clinical diagnosis of endometriosis: a call to action
10.1016/j.ajog.2018.12.039 · 2019
Rethinking mechanisms, diagnosis and management of endometriosis
10.1038/s41574-019-0245-z · 2019
ESHRE guideline: endometriosis
10.1093/hropen/hoac009 · 2022
Salivary MicroRNA signature for diagnosis of endometriosis
10.3390/jcm11030612 · 2022
Non-invasive diagnosis of endometriosis: the goal or own goal?
10.1093/humrep/deq141 · 2010
Urinary biomarkers for the non-invasive diagnosis of endometriosis
2015
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Blood biomarkers for the non-invasive diagnosis of endometriosis
2016
Combination of the non-invasive tests for the diagnosis of endometriosis
2016
Differential diagnosis of endometriosis by ultrasound: a rising challenge
10.3390/diagnostics10100848 · 2020
Accurate diagnosis of endometriosis using serum microRNAs
10.1016/j.ajog.2020.02.050 · 2020
Clinical characteristics and pregnancy outcomes of infertile patients with endometriosis and endometrial polyps: a retrospective cohort study
10.1016/j.tjog.2020.09.020 · 2020
Endometriosis and uterine fibroids (leiomyomata): comorbidity, risks and implications
10.3389/frph.2021.750018 · 2021
Association of endometriosis and adenomyosis with pregnancy and infertility
10.1016/j.fertnstert.2023.03.018 · 2023
Epidemiology of adenomyosis
2020
The harms of screening: a proposed taxonomy and application to lung cancer screening
10.1001/jamainternmed.2013.12745 · 2014
Does screening for disease save lives in asymptomatic adults? Systematic review of meta-analyses and randomized trials
10.1093/ije/dyu140 · 2015
Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal
10.1093/humrep/dev157 · 2015
How to prevent overdiagnosis
10.4414/smw.2015.14060 · 2015
Principles for high-quality, high-value testing
10.1136/eb-2012-100645 · 2013
How to: evaluate a diagnostic test
10.1016/j.cmi.2018.06.011 · 2019
Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing directive 98/79/EC and Commission Decision 2010/227/EU
2017
STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies
10.1136/bmj.h5527 · 2015
Diagnostic test evaluation methodology: a systematic review of methods employed to evaluate diagnostic tests in the absence of gold standard – An update
10.1371/journal.pone.0223832 · 2019
Unresolved referenced work
1980
Quantification of harms in cancer screening trials: literature review
10.1136/bmj.f5334 · 2013
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
10.1016/s0140-6736(21)00731-5 · 2021
Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
10.1038/s41585-022-00638-6 · 2022
Current policies on early detection of prostate cancer create overdiagnosis and inequity with minimal benefit
10.1136/bmj-2022-071082 · 2023
No additional external references are available.